Apheris ensures secure, private data access for ML and analytics, enabling federated data networks while protecting IP and privacy
HQ
Germany
Founded
2019
Employees
40
Apheris enables governed, private, and secure access to data for machine learning (ML) and analytics. In an era where model architectures are increasingly commoditised, data becomes an organisation’s key differentiator. Businesses need to safeguard their data assets and intellectual property while leveraging them for ML, and Apheris provides the solution.
The Apheris Compute Gateway ensures that only approved computations can be launched on your data. It enables federation across organisational boundaries, allowing ML-powered insights without the need to centralise data. This ensures compliance with data privacy, security, and governance obligations.
Apheris offers a Co-Folding Application that allows users to predict the 3D structure of macromolecule complexes with an emphasis on protein-ligand, protein-protein, and antibody-antigen interfaces using OpenFold3 and Boltz-2. This application features local deployment within minutes, streamlined data preparation using built-in quality controls, and benchmarking and inference functionality.
Apheris powers federated data networks, addressing the challenge of collaboratively training higher-quality models on data from multiple parties while keeping data IP and confidentiality protected. This is particularly crucial in the life sciences sector, where proprietary data is stored in private repositories due to IP and privacy concerns.
Apheris provides the technology layer for the Artificial Intelligence Structural Biology (AISB) Network, a collaboration among leading biopharma companies aimed at transforming AI drug discovery. State-of-the-art AI models are trained and evaluated on unique data from multiple companies without exposing proprietary information.
Apheris is headquartered in Berlin, Germany. Founded in 2019, the company has quickly established itself as a leader in data governance and privacy solutions for machine learning and analytics.
Apheris is backed by top investors and tech industry innovators, including Octopus Ventures, Heal Capital, LocalGlobe, another.vc, MuleSoft founder Ross Mason (Dig Ventures), and Twitter board chairman and former CFO of Google Patrick Pichette. The company is trusted by leading biopharma companies for its secure and governed data access solutions.
With a team of 40 employees, Apheris is dedicated to advancing life sciences research with governed access to distributed, multi-modal healthcare data. The company’s growth and success are driven by its commitment to enabling collaborative work across boundaries while ensuring compliance with data privacy and security regulations.
Explore other tools in this category
Usercentrics provides privacy compliance solutions, managing user consent for websites and apps
Consentmanager.net, a GDPR-compliant consent management platform supporting over 30 languages, ensures websites meet data governance and privacy standards.
Evervault, based in Dublin, offers a flexible security platform for payments, enabling control, compliance and avoiding vendor lock-in